| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |